The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Selenium and the Course of Mild Graves' Orbitopathy
Open accessAbstract
BACKGROUND: Oxygen free radicals and cytokines play a pathogenic role in Graves' orbitopathy. METHODS: We carried out a randomized, double-blind, placebo-controlled trial to determine the effect of selenium (an antioxidant agent) or pentoxifylline (an antiinflammatory agent) in 159 patients with mild Graves' orbitopathy. The patients were given selenium (100 μg twice daily), pentoxifylline (600 mg twice daily), or placebo (twice daily) orally for 6 months and were then followed for 6 months after treatment was withdrawn. Primary outcomes at 6 months were evaluated by means of an overall ophthalmic assessment, conducted by an ophthalmologist who was unaware of the treatment assignments, and a Graves' orbitopathy-specific quality-of-life questionnaire, completed by the patient. Secondary outcomes were evaluated with the use of a Clinical Activity Score and a diplopia score. RESULTS: At the 6-month evaluation, treatment with selenium, but not with pentoxifylline, was associated with an improved quality of life (P<0.001) and less eye involvement (P=0.01) and slowed the progression of Graves' orbitopathy (P=0.01), as compared with placebo. The Clinical Activity Score decreased in all groups, but the change was significantly greater in the selenium-treated patients. Exploratory evaluations at 12 months confirmed the results seen at 6 months. Two patients assigned to placebo and one assigned to pentoxifylline required immunosuppressive therapy for deterioration in their condition. No adverse events were evident with selenium, whereas pentoxifylline was associated with frequent gastrointestinal problems. CONCLUSIONS: Selenium administration significantly improved quality of life, reduced ocular involvement, and slowed progression of the disease in patients with mild Graves' orbitopathy. (Funded by the University of Pisa and the Italian Ministry for Education, University and Research; EUGOGO Netherlands Trial Register number, NTR524.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482
The importance of selenium to human health
Rayman, M. P. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02490-9 · Cited by 4,163
Bahn, R. S. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0905750 · Cited by 1,552
Clinical activity score as a guide in the management of patients with Graves' ophthalmopathy
Mourits, M. P., Prummel, M. F., Wiersinga, W. M., & Koornneef, L. (1997) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1997.2331047.x · Cited by 1,001
Self-citationFood-chain selenium and human health: emphasis on intake
Rayman, M. P. (2008) · British Journal of Nutrition · doi:10.1017/s0007114508939830 · Cited by 798
Consensus statement of the European Group on Graves' orbitopathy (EUGOGO) on management of GO
Bartalena, L., Baldeschi, L., Dickinson, A., Eckstein, A., Kendall-Taylor, P., Marcocci, C., Mourits, M., Perros, P., Boboridis, K., Boschi, A., et al. (2008) · European Journal of Endocrinology · doi:10.1530/eje-07-0666 · Cited by 795
Self-citationManagement of Graves’ Ophthalmopathy: Reality and Perspectives*
Bartalena, L., Pinchera, A., & Marcocci, C. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.2.0393 · Cited by 677
Self-citationThe influence of selenium on immune responses
Hoffmann, P. R., & Berry, M. J. (2008) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200700330 · Cited by 544
Current Perspective on the Pathogenesis of Graves’ Disease and Ophthalmopathy
Prabhakar, B. S., Bahn, R. S., & Smith, T. J. (2003) · Endocrine Reviews · doi:10.1210/er.2002-0020 · Cited by 489
Terwee, C. B., Gerding, M. N., Dekker, F. W., Prummel, M. F., & Wiersinga, W. M. (1998) · British Journal of Ophthalmology · doi:10.1136/bjo.82.7.773 · Cited by 321
Self-citationGirolami, B., Bernardi, E., Prins, M. H., ten Cate, J. W., Hettiarachchi, R., Prandoni, P., Girolami, A., & Büller, H. R. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.4.337 · Cited by 253
Natural history of thyroid associated ophthalmopathy
Perros, P., Cromble, A. L., & Kendall‐Taylor, P. (1995) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1995.tb02597.x · Cited by 219
GERDING, M. N., TERWEE, C. B., DEKKER, F. W., KOORNNEEF, L., PRUMMEL, M. F., & WIERSINGA, W. M. (1997) · Thyroid · doi:10.1089/thy.1997.7.885 · Cited by 217
Self-citationDickinson, A. J., & Perros, P. (2001) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2001.01349.x · Cited by 210
Terwee, C. B., Dekker, F. W., Mourits, M. P., Gerding, M. N., Baldeschi, L., Kalmann, R., Prummel, M. F., & Wiersinga, W. M. (2001) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2001.01241.x · Cited by 202
Self-citationPentoxifylline in the Treatment of Radiation-Induced Fibrosis
Okunieff, P., Augustine, E., Hicks, J. E., Cornelison, T. L., Altemus, R. M., Naydich, B. G., Ding, I., Huser, A. K., Abraham, E. H., Smith, J. J., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.09.101 · Cited by 163
Choice of Therapy and Criteria for Assessing Treatment Outcome in Thyroid-associated Ophthalmopathy
Bahn, R. S., & Gorman, C. A. (1987) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(18)30485-7 · Cited by 159
Nacamulli, D., Mian, C., Petricca, D., Lazzarotto, F., Barollo, S., Pozza, D., Masiero, S., Faggian, D., Plebani, M., Girelli, M. E., et al. (2009) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2009.03758.x · Cited by 120
Vrca, V. B., Škreb, F., Čepelak, I., Romić, Ž., & Mayer, L. (2004) · Clinica Chimica Acta · doi:10.1016/j.cccn.2003.10.028 · Cited by 98
Abalovich, M., Llesuy, S., Gutierrez, S., et al. (2003) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2003.01850.x · Cited by 92
Antioxidant agents in the treatment of Graves’ ophthalmopathy
Bouzas, E. A., Karadimas, P., Mastorakos, G. P., & Koutras, D. A. (2000) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(00)00359-7 · Cited by 82
Serum Selenium Levels in Patients with Remission and Relapse of Graves Disease
Wertenbruch, T., Willenberg, H. S., Sagert, C., Nguyen, T.-B.-T., Pavlicek‐Bahlo, M., Feldkamp, J., Groeger, C., Hermsen, D. F., Scherbaum, W. A., & Schott, M. (2007) · Medicinal Chemistry · doi:10.2174/157340607780620662 · Cited by 71
Burney, P., Potts, J., Makowska, J. S., Kowalski, M. L., Phillips, J. A., Gnatiuc, L., Shaheen, S. O., Joos, G. F., Cauwenberge, P. V., Zele, T. V., et al. (2008) · Allergy · doi:10.1111/j.1398-9995.2008.01716.x · Cited by 62
Dezube, B. J., Sherman, M. L., Fridovich‐Keil, J. L., Allen-Ryan, J., & Pardee, A. B. (1993) · Cancer Immunology Immunotherapy · doi:10.1007/bf01789132 · Cited by 60
Determination of oxidative stress in thyroid tissue and plasma of patients with Graves' disease
Ademoğlu, E., Özbey, N., Erbil, Y., Tanrıkulu-Küçük, S., Barbaros, U., Yanık, B. T., Bozbora, A., & Özarmağan, S. (2006) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2006.04.013 · Cited by 60
Selenium and thyroid autoimmunity
Negro, R. (2008) · Biologics · doi:10.2147/btt.s2746 · Cited by 54
Anaya, J., & Espinoza, L. R. (1995) · PubMed · Cited by 29
Cited by
Rayman, M. P. (2012) · The Lancet · doi:10.1016/s0140-6736(11)61452-9 · Cited by 3,563
Garber, J. R., Cobin, R. H., Gharib, H., Hennessey, J. V., Klein, I., Mechanick, J. I., Pessah-Pollack, R., Singer, P. A., & Woeber, K. A. (2012) · Endocrine Practice · doi:10.4158/ep12280.gl · Cited by 1,567
Smith, T. J., & Hegedüs, L. (2016) · New England Journal of Medicine · doi:10.1056/nejmra1510030 · Cited by 1,257
Bartalena, L., Kahaly, G. J., Baldeschi, L., Dayan, C. M., Eckstein, A., Marcocci, C., Marinò, M., Vaidya, B., Wiersinga, W. M., _, _., et al. (2021) · European Journal of Endocrinology · doi:10.1530/eje-21-0479 · Cited by 1,054
Self-citationGarber, J. R., Cobin, R. H., Gharib, H., Hennessey, J. V., Klein, I., Mechanick, J. I., Pessah-Pollack, R., Singer, P. A., & Woeber for the American Association, K. A. (2012) · Thyroid · doi:10.1089/thy.2012.0205 · Cited by 1,053
Metadata
- Authors
- Marcocci, C., Kahaly, G. J., Krassas, G. E., Bartalena, L., Prummel, M., Stahl, M., Altea, M. A., Nardi, M., Pitz, S., Boboridis, K., Sivelli, P., von Arx, G., Mourits, M. P., Baldeschi, L., Bencivelli, W., & Wiersinga, W.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2011-05-19
- Volume
- 364
- Issue
- 20
- Pages
- 1920-1931
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2110465047
- Cited by
- 619
- References
- 27
- FWCI
- 25.41
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.